We are on a mission to revolutionize healthcare using technology and personalized attention.
More specifically, PDxS seeks to equalize the playing field by making expert-level pathology secondary consultations available to anyone, anytime, anywhere around the globe.
It is estimated that pathology impacts as much as 70% of all healthcare decisions. Additionally, as many as 29% of cases sent for second opinions result in major discrepancies and significantly altered patient therapy. These errors rate that may be present worldwide.
PDxS connects pathology subspecialists to referring pathologists, providers, and patients leveraging digital pathology technology and platforms in a way, eliminating the inefficiencies of traditional processes and increasing access to high quality care for all.
It’s something we like to call Pathology, connected.
• PDxS is a wholly-owned subsidiary of NeoDiagnostics and focuses on the Pathology Diagnostic set of services.
